Condition: Spondylitis, Ankylosing · Mobile Phone Use · Sponsor: Wuerzburg University Hospital
This prospective, multicenter, controlled real-world quality management study explores the acceptance and utility of two measures discussed in the context of the German Digital Act (DigiG) for the digital health application (DiGA) Axia: a 14-day trial period and an application-related outcome measurement (AbEM). Patients with axial spondyloarthritis in Axia's indication area who are eligible for prescription in routine care will receive one of two onboarding brochure versions in a 1:1 allocation: either the standard access procedure or immediate 14-day trial access until the health insurance activation code arrives. The manufacturer will analyze aggregated anonymized data to compare voucher redemption and app activation frequencies between groups and to assess acceptance and return rates of a voluntary five-item AbEM questionnaire at weeks 6 and 12. Secondary analyses will descriptively evaluate AbEM results and anonymized usage data.
This description comes directly from the study's public registry record.
Patrick-Pascal Strunz, MD · 093120140100 · Strunz_p@ukw.de
Patrick-Pascal Strunz · 093120140100 · Strunz_p@ukw.de
Always discuss trial participation with your own doctor first.
| University Hospital of Wuerzburg | Würzburg, Bavaria, Germany | Recruiting |
| Praxisgemeinschaft Rheumatologie Nephrologie Erlangen | Erlangen, Germany | Recruiting |
| University Hospital of Erlangen | Erlangen, Germany | Recruiting |
| MVZ Rheumatologie | Hamburg, Germany | Recruiting |
| Rheumatologische Gemeinschaftspraxis Hattingen | Hattingen, Germany | Recruiting |
| University Hospital of Marburg | Marburg, Germany | Recruiting |
| Klinikum Nürnberg | Nuremberg, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07561255